UNSPSC 51283218: Mepartricin a

This classification denotes a macrolide antibiotic with the molecular formula C60H88N2O19, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L13V8793FQ, chemically known as candicidin d, 40-demethyl-3,7-dideoxo-3,7-dihydroxy-n47-methyl-5-oxo-, methyl ester, cyclic 15,19-hemiacetal, but more generally known as mepartricin a, which bears US NIH Compound Identifier 3009010. European Medicines Agency schedules mepartricin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03153MIG.

Most nations, for tariff purposes, schedule mepartricin a under HS 29419000. SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC\2CC3C(C(CC(O3)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC(C(/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C)C(C)CCC(CC(=O)C4CCC(CC4)NC)O)O)O)O)O)O)O)O)C(=O)OC)O)N)O.

UNSPSC 51283218 Mepartricin a (Commodity) names a pharmaceutical ingredient, but recent state and local solicitations tagged with this code are procuring finished pharmaceutical products and medical supplies—naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic pharmaceuticals and over-the-counter products for state health systems. State and local governments are buying these items through their health departments, emergency services, and cooperative purchasing alliances to stock emergency response systems, pharmacy benefit programs, and clinical inventories. Issuing bodies include county health departments, state health and human services commissions, city fire departments, and multistate cooperative purchasing organizations that aggregate demand across participating jurisdictions. The nature of these opportunities—stocking consumables, managing drug access and cost, and filling emergency supply needs—suggests the code may be misapplied to products outside its nominal scope, or the taxonomy is being used to cast a wider net for pharmaceutical-adjacent procurement.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries and a July 26, 2023 response date, under an initial two-year term with optional one-year renewal. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to solicit vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program. The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies to support the Tampa Fire Department Rescue Division—a $700,000 estimated contract sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic pharmaceuticals and OTC products effective July 1, 2026, with proposals due March 26, 2026 and evaluation weighted 75 percent on price competitiveness.